Dubai’s Medcare Hospital Becomes the World’s First to Treat an Adult Spinal Muscular Atrophy (SMA) Patient Outside the US

Contributed by: Business Wire

Logo

Images

Dr. Vivek Mundada with Medcare multidisciplinary medical team (Photo: AETOSWire)

Business Wire embedded0

Tags

Health

Hospitals

Neurology

Genetics

Pharmaceutical

Biotechnology

Medcare

More Like This

World's first international patient, who received intrathecal gene therapy at Medcare Royal Hospital in Dubai, UAE, along with parents, and the hospital team. (Photo: AETOSWire)

UAE’s Medcare Treats First International SMA Patient With Revolutionary Intrathecal Gene Therapy

PR Newswire associated0

The Department of Health - Abu Dhabi provides gene therapy for Duchenne Muscular Dystrophy for the first time in Abu Dhabi and outside the US

SK pharmteco and GEMMABio Expand Rare Disease Manufacturing Collaboration Following Important Spinal Muscular Atrophy (SMA) Clinical Trial Milestone

UCSF Benioff Children's Hospitals Become the First US Qualified Treatment Center Contracted to Administer Individualized Gene Therapy WASKYRA®

Every baby in England to get life-saving genetic test from birth

baby Aiyla,

A heartbreaking race against time: £600,000 needed to save 9-month-old UK baby Aiyla's life, Zolgensma is the only hope against SMA type 1.

PR Newswire associated0

Abu Dhabi Stem Cells Center Successfully Manufactures UAE's First CAR-T Cell to Treat an 11-Year Old Leukemia Patient

Vertex Announces Approval of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™, for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT) in Kingdom of Saudi Arabia